Mission

Fueled by innovation to contribute to health and well-being, we’re developing the next generation of smarter, non-invasive, non-radiation medical technology - the MR-guided High Intensity Focused Ultrasound. Consistently delivering better treatment solutions through comprehensive, efficient, safer and precise clinical practices to relieve pain, restore health and extend life

Vision

To be a leader of Focused Ultrasound medical technology in transforming the treatments of whole person care. We aim to be recognized for innovation, commitment and high standards in quality for healthcare products

Our Story

2013

[ Company Founded ]
Spun off from NHRI, Taiwan

2016

[ ABUS Whole Breast Ultrasound Platform ]
TFDA Medical Device Class I

[ ArcBlate Focused Ultrasound Ablation System ]
clinical trials for uterine fibroids completed at Chang Gung Memorial Hospital, Linkou
TFDA Medical Device Class II

2017

[ ArcBlate Focused Ultrasound Ablation System ]
Frost & Sullivan 2017 HIFU Product Innovation Award
Lease agreement with Far Eastern Memorial Hospital

2018

[ ABUS Whole Breast Ultrasound Platform ]
Collaboration agreement with Hitachi, Ltd.
TFDA Medical Device Class II

2019

[ ABUS Automated Whole Breast Ultrasound Platform ]
Winner of National Innovation Award, Taiwan

2021

[ ArcBlate Focused Ultrasound Ablation System ]
TFDA Medical Device Class III
Lease agreement with Dalin Tzu Chi Hospital

2023

[ ArcBlate Focused Ultrasound Ablation System ]
Lease agreement with HuaLien Tzu Chi Hospital
Approved by IDE to carry out pivotal clinical for pain palliation of bone metastases
Innovation Award -Gold Medal Taipei

2024

[ ArcBlate Focused Ultrasound Ablation System ]
Indonesia MOH approved- Class C
Presence & Sponsor in International Society for Therapeutic Ultrasound (ISTU) Taipei

Treament Centers

Our Partners